If the number of men with newly diagnosed prostate cancer who opted for watchful waiting increased from 10 percent to 50 percent, the resulting savings would surpass $1 billion, researchers estimated in a study published June 18 in Annals of Internal Medicine. The authors noted that new molecular imaging techniques could improve classification of low-risk candidates and set the stage for a more conservative approach than the active surveillance model.